HALL LAURIE J TRUSTEE - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 136 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$1
-100.0%
85
-34.6%
0.00%
-100.0%
Q3 2022$2,000
+100.0%
130
+44.4%
0.00%
Q2 2022$1,0000.0%900.0%0.00%
Q1 2022$1,0000.0%900.0%0.00%
Q4 2021$1,0000.0%900.0%0.00%
Q3 2021$1,000
-66.7%
90
-35.7%
0.00%
-100.0%
Q2 2021$3,0000.0%1400.0%0.00%0.0%
Q1 2021$3,0000.0%1400.0%0.00%0.0%
Q4 2020$3,000
-50.0%
1400.0%0.00%
-66.7%
Q3 2020$6,000
-50.0%
140
+40.0%
0.00%
-50.0%
Q4 2019$12,000
+140.0%
100
+25.0%
0.01%
+100.0%
Q3 2019$5,000
+25.0%
80
+60.0%
0.00%
+50.0%
Q2 2019$4,000
-33.3%
500.0%0.00%
-33.3%
Q1 2019$6,0000.0%500.0%0.00%0.0%
Q4 2018$6,000
-25.0%
50
-16.7%
0.00%
-25.0%
Q3 2018$8,000
+60.0%
600.0%0.00%
+33.3%
Q2 2018$5,000
+25.0%
600.0%0.00%
+50.0%
Q1 2018$4,0000.0%600.0%0.00%0.0%
Q4 2017$4,000600.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 635,300$39,083,0009.04%
Senvest Management, LLC 1,152,032$70,873,0005.40%
Melqart Asset Management (UK) Ltd 298,200$18,345,0002.20%
Elk Creek Partners, LLC 348,454$21,437,0001.25%
ALTRINSIC GLOBAL ADVISORS LLC 375,223$23,084,0000.93%
BB BIOTECH AG 545,719$33,573,0000.93%
Virtus ETF Advisers LLC 14,681$903,0000.78%
Opus Point Partners Management, LLC 4,496$277,0000.54%
Spark Investment Management LLC 136,500$8,397,0000.54%
Regal Investment Advisors LLC 29,511$1,816,0000.40%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders